Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

PET Detection of CCR2 in Human Atherosclerosis

Washington University School of Medicine · NCT04537403

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–89 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
100
US sites recruiting
1
Study start
October 1, 2020
Record last updated
August 1, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis

Being studied: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine); Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)

Conditions: Carotid Atherosclerosis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria: Normal Volunteers: 18-40 years of age, non smoker, no history of diabetes, hypertension, or hyperlipidemia. Patients: 50-89 years of age, adequate nutritional status, with or without smoking history, diabetes, hypertension, and hyperlipidema. Both asymptomatic and symptomatic patients with known carotid artery atherosclrosis >70% and scheduled to undergo surgery. Advanced peripheral artery disease.

-

Exclusion Criteria:Inability to receive and sign informed consent. Currently enrolled in another study. Patients who have type 1 diabetes or are in septic shock, receiving steroid therapy, recent history of heavy alcohol consumption, (male >2 drinks per day, and female > 1 drink per day. following extreme diets like Atkins or South Beach diet or with Stage 4 chronic renal failure. Patients with unstable clinical condition that in the opinion of the PI precludes participation in the study. Inability to tolerate 60 minutes in a supine position with arms down at sides. Contraindications to MR imaging, (pacemaker, brain aneurysm clips, shrapnel, etc. Positive pregnancy test or lactating. Have another conditions such as cancer or autoimmune/inflammatory diseases, e.g. rheumatoid arthritis or multiple sclerosis that are known to have increased expression of CCR2.

-

Recruiting US locations

  • Washington University CCIR

    St Louis, MO 63110

    Site contact: Molly Mohrman

Study contacts (from the official record)

  • Kitty Harrison, BSN, RN · 314-747-0183 · harrisonk@mir.wustl.edu
  • Robert Gropler, M.D. · 314-747-0183 · groplerr@mir.wustl.edu
PET Detection of CCR2 in Human Atherosclerosis (NCT04537403) | Bored Studies